The frequency of mitochondrial polymerase gamma related disorders in a large Polish population cohort.

[1]  R. Płoski,et al.  Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations , 2018, Journal of Human Genetics.

[2]  Yong-hui Jiang,et al.  Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing , 2017, Scientific Reports.

[3]  W. Copeland,et al.  DNA polymerases in the mitochondria: A critical review of the evidence. , 2017, Frontiers in bioscience.

[4]  P. Amati‐Bonneau,et al.  The wide POLG-related spectrum: An integrated view , 2016, Journal of the Neurological Sciences.

[5]  R. Płoski,et al.  New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre , 2016, Journal of Translational Medicine.

[6]  R. Płoski,et al.  Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing , 2016, Molecular genetics and metabolism reports.

[7]  C. Lam,et al.  Novel POLG mutation in a patient with sensory ataxia, neuropathy, ophthalmoparesis and stroke. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[8]  P. Golik,et al.  Yeast model analysis of novel polymerase gamma variants found in patients with autosomal recessive mitochondrial disease , 2015, Human Genetics.

[9]  Robert W. Taylor,et al.  SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  C. Richelme,et al.  Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort , 2013, European Journal of Human Genetics.

[11]  E. Jamroz,et al.  The natural history of SCO2 deficiency in 36 Polish children confirmed the genotype-phenotype correlation. , 2013, Mitochondrion.

[12]  Jeffrey D. Stumpf,et al.  Clinical and molecular features of POLG-related mitochondrial disease. , 2013, Cold Spring Harbor perspectives in biology.

[13]  R. Naviaux,et al.  Alpers-Huttenlocher syndrome. , 2013, Pediatric neurology.

[14]  T. Hedderly,et al.  Prospective study of POLG mutations presenting in children with intractable epilepsy: Prevalence and clinical features , 2013, Epilepsia.

[15]  M. Zeviani,et al.  Screening for POLG W748S and A467T mutations in ataxia patients from Spain , 2012, Movement disorders : official journal of the Movement Disorder Society.

[16]  S. Seneca,et al.  Polymerase gamma deficiency (POLG): clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh's encephalopathy. , 2012, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[17]  L. Schöls,et al.  Characterizing POLG Ataxia: Clinics, Electrophysiology and Imaging , 2012, The Cerebellum.

[18]  M. Martikainen,et al.  Progressive External Ophthalmoplegia in Southwestern Finland: A Clinical and Genetic Study , 2012, Neuroepidemiology.

[19]  N. Larsson,et al.  Complete Deletion of a POLG1 Allele in a Patient with Alpers Syndrome. , 2012, JIMD reports.

[20]  Robert W. Taylor,et al.  Sensory neuronopathy in patients harbouring recessive polymerase γ mutations. , 2012, Brain : a journal of neurology.

[21]  M. Milone,et al.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations , 2012, Journal of Neurology.

[22]  W. Craigen,et al.  Mitochondrial DNA polymerase γ mutations: an ever expanding molecular and clinical spectrum , 2011, Journal of Medical Genetics.

[23]  G. Węgrzyn,et al.  Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[24]  L. Schöls,et al.  CSF Aβ42 and tau in Parkinson's disease with cognitive impairment , 2010, Movement disorders : official journal of the Movement Disorder Society.

[25]  M. Martikainen,et al.  Novel POLG1 mutations in a patient with adult-onset progressive external ophthalmoplegia and encephalopathy , 2010, BMJ Case Reports.

[26]  B. Andresen,et al.  A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland , 2010, Journal of Inherited Metabolic Disease.

[27]  L. Schöls,et al.  ATAXIA WITH OPHTHALMOPLEGIA OR SENSORY NEUROPATHY IS FREQUENTLY CAUSED BY POLG MUTATIONS , 2009, Neurology.

[28]  H. Smeets,et al.  The unfolding clinical spectrum of POLG mutations , 2009, Journal of Medical Genetics.

[29]  A. Amiot,et al.  Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. , 2009, Gastroenterology.

[30]  M. Pronicki,et al.  High prevalence of SURF1 c.845_846delCT mutation in Polish Leigh patients. , 2009, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[31]  A. Pagnamenta,et al.  Analysis of mutant DNA polymerase γ in patients with mitochondrial DNA depletion , 2009, Human mutation.

[32]  J. Ganesh,et al.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations , 2008, Human mutation.

[33]  N. Ashley,et al.  Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations , 2008, Human molecular genetics.

[34]  M. Zeviani,et al.  155th ENMC workshop: Polymerase gamma and disorders of mitochondrial DNA synthesis, 21–23 September 2007, Naarden, The Netherlands , 2008, Neuromuscular Disorders.

[35]  D. Turnbull,et al.  MELAS ASSOCIATED WITH MUTATIONS IN THE POLG1 GENE , 2007, Neurology.

[36]  S. Dimauro,et al.  Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders , 2007, European Journal of Human Genetics.

[37]  M. Zeviani,et al.  The A467T and W748S POLG substitutions are a rare cause of adult-onset ataxia in Europe. , 2006, Brain : a journal of neurology.

[38]  W. Copeland,et al.  Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders. , 2006, Human molecular genetics.

[39]  R. Rodenburg,et al.  Mitochondrial disease criteria , 2006, Neurology.

[40]  E. Ciara,et al.  SLOS carrier frequency in Poland as determined by screening for Trp151X and Val326Leu DHCR7 mutations. , 2006, European journal of medical genetics.

[41]  Robert W. Taylor,et al.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary , 2006 .

[42]  M. Zeviani,et al.  The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. , 2006, Brain : a journal of neurology.

[43]  W. Copeland,et al.  The Common A467T Mutation in the Human Mitochondrial DNA Polymerase (POLG) Compromises Catalytic Efficiency and Interaction with the Accessory Subunit* , 2005, Journal of Biological Chemistry.

[44]  A. Paetau,et al.  Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. , 2005, American journal of human genetics.

[45]  D. Turnbull,et al.  Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase γ mutations , 2005, Neurology.

[46]  M. Zeviani,et al.  Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. , 2005, Brain : a journal of neurology.

[47]  L. Kaguni.  DNA Polymerase γ, The Mitochondrial Replicase1 , 2004 .

[48]  C. Broeckhoven,et al.  Digenic progressive external ophthalmoplegia in a sporadic patient: Recessive mutations in POLG and C10orf2/Twinkle , 2003, Human mutation.

[49]  C. Broeckhoven,et al.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions , 2001, Nature Genetics.